SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017604
Filing Date
2022-11-14
Accepted
2022-11-14 08:17:18
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20220930x10q.htm   iXBRL 10-Q 1632343
2 EX-31.1 cgtx-20220930xex31d1.htm EX-31.1 16276
3 EX-31.2 cgtx-20220930xex31d2.htm EX-31.2 16779
4 EX-32.1 cgtx-20220930xex32d1.htm EX-32.1 9976
5 EX-32.2 cgtx-20220930xex32d2.htm EX-32.2 10007
  Complete submission text file 0001558370-22-017604.txt   6057956

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20220930.xsd EX-101.SCH 37579
7 EX-101.CAL cgtx-20220930_cal.xml EX-101.CAL 47652
8 EX-101.DEF cgtx-20220930_def.xml EX-101.DEF 126980
9 EX-101.LAB cgtx-20220930_lab.xml EX-101.LAB 393938
10 EX-101.PRE cgtx-20220930_pre.xml EX-101.PRE 284099
53 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20220930x10q_htm.xml XML 988239
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 221380534
SIC: 2836 Biological Products, (No Diagnostic Substances)